Genomic Profiling of Haematological Malignancies using Archer NGS Panels—The HSL Experience

Genomic Profiling of Haematological Malignancies using Archer NGS Panels—The HSL Experience

Identification of genetic alterations through next generation sequencing (NGS) can guide decision‐making by providing insights on myeloid and lymphoid malignancies through targeted NGS, particularly with rare fusions.

In this webinar, HSL presents case studies on their experience implementing Archer FUSIONPlex™, VARIANTPlex™, and IMMUNOVerse™ assays for profiling haematological malignancies.

Learn why they chose the panels, how they were implemented in the lab, and their experience with the chemistry, workflows, and analysis software.

Published on: February 11, 2025